Investor Relations

May 23, 2013
OPKO Surpasses 50% Enrollment in First Phase 3 Trial of RayaldyTM (CTAP101 Capsules) more »

May 9, 2013
OPKO Announces First Quarter 2013 Operating and Financial Highlights more »

Apr 24, 2013
OPKO Health To Acquire PROLOR Biotech more »

Apr 18, 2013
OPKO Health Acquires Interest in Growing Russian Pharmaceutical Company more »

Conferences & Events

Featured Events

Jan 8, 2013
4:00 PM PT

OPKO Health to Present at the 31st Annual J.P. Morgan Healthcare Conference

	View OPKO Health Presentation 1.9 MB
OPKO Health to Acquire Two Phase 3 Products
	View Cytochroma Presentation 527.0 KB

Upcoming Events
Details on upcoming events are not yet available.